Medinol is dedicated to the science of cardiovascular intervention. Medinol develops, manufactures, and markets EluNIR, an elastomeric drug-eluting stent made from a thin cobalt-chrome alloy and recognized for its optimal balance between flexibility, conformability, scaffolding, and low metal footprint. EluNIR offers a new level of uniform drug elution and surface quality and demonstrated excellent clinical outcomes and long-term safety profile in clinical studies. EluNIR features the novel Flexx catheter technology with a visible metallic spring tip that eliminates tip flare-out and buckling. Flexx overcomes standard polymer tip limitations, offering both superb flexibility and uncompromised crossability, resulting in unprecedented ease of delivery even in complex anatomies.